Sheba Medical Center’s ARC innovation arm has launched and inaugurated HaMeirim – ARC Cardiovascular (“The Radiant Ones” or “Those who shine”), a dedicated innovation center for the Heart, Thorax, and Vascular Center.
In a groundbreaking collaboration, Sheba Medical Center and Bar-Ilan University have established Israel’s first dedicated biotech research institute. Supported by a $120 million investment and situated within Sheba’s new Health Tech Valley in Ramat Gan, this pioneering center is set to accelerate breakthroughs in cancer treatment, AI-driven diagnostics, organ printing, and genetic engineering.
ARC at Sheba Medical Center has appointed Level Ex founder Sam Glassenberg as Head of Emerging HealthTech Initiatives. A pioneer in medical gaming and AI, Glassenberg will lead efforts to integrate immersive technologies into clinical care, developing new models for training, diagnosis, and patient engagement. This milestone marks Sheba’s latest step in advancing global healthcare through innovation.
A groundbreaking three-year partnership bringing together NVIDIA, Sheba’s ARC Innovation Center, and the Icahn School of Medicine at Mount Sinai was announced on November 18, 2025. The partnership aims to harness artificial intelligence (AI) through large language models (LLMs) to decode the 98% of the human genome that remains unexplored, paving the way for novel approaches in disease prevention, diagnosis, and precision medicine worldwide.
This year, Sheba Global Ophthalmology (SGO) was honored to send Dr. Yael Lustig-Barzelay of the Goldschleger Eye Institute, Sheba Medical Center, to the EURETINA 2025 Congress in Paris—Europe’s leading gathering for retinal specialists. The meeting offered her a platform to share Sheba’s latest research, exchange knowledge with international colleagues, and reflect on how both innovation and long-established clinical experience continue to shape ophthalmic care worldwide.
In a landmark step toward accelerating healthcare innovation across the Asia-Pacific region, Sheba’s ARC Innovation Center has signed a Memorandum of Understanding (MOU) with the China Medical University (CMU) in Taiwan to establish a new ARC site within CMU’s Biopark.
